GERMANTOWN, Maryland, July 2, 2012 /PRNewswire/ --
Medispec, a world leader in non-invasive medical solutions, announced today that its ED-1000 solution has been found to be an effective treatment for erectile dysfunction (ED) by leading urologists around the world. The solution has been proven as a clinically effective alternative to pharmacological solutions (Phosphodiesterase 5 inhibitors) - such as Cialis, Viagra or Levitra - and dramatically reduces the need for treatments that require vacuum pumps, injections or implants.
As a non-invasive, drug-free treatment, the ED-1000 triggers the body's natural repair mechanisms, returning spontaneity to the bedroom. The technology - designed specifically to treat the underlying cause of vascular-related ED - is based on the use of low-intensity extracorporeal shockwaves to improve the volume of blood flow within the body. The shockwaves stimulate the creation of new microvascular blood vessel networks that increase the blood supply to erectile tissue. Extensive clinical trials have shown that the increased blood supply enables the patient to achieve and maintain firm erections for a minimum of two years following treatment.
The twenty minute ED-1000 treatment - repeated several times over a number of weeks - has produced positive results in over thirty countries, including the UK, Spain, Germany, Japan, Thailand, Canada, France and more. In the US, the ED-1000 is limited to investigational use.
A twenty year track record of providing high performance shockwave technology systems customized to client needs has made Medispec the company to turn to for non-invasive Cardiology, Urology, Orthopedics, physiotherapy, and cellulite control applications. Known for superior quality, excellent results, cost-efficiency, on-time delivery and dedicated service, Medispec works with physicians and clinics in 80 countries. All Medispec products comply with FDA and CE regulations.
Visit the Medispec website at :
SOURCE Medispec Ltd.